Global Life Science Instrumentation Market Share, Trends & Forecast to 2025

Recent advancement such as microarray-based expression profiling in genomics, proteomics and drug discovery domains, created new possibilities for the diagnosis and treatment of various fatal diseases such as Cancer and CVD. The life science instrument supported R&D programs and other research studies to discover and develop safe and effective drugs for various chronic diseases including Cancer, Diabetes, and neurological diseases, among others. Research programs related to human genetics have been analyzed in combination with health data and have become increasingly vital for understanding the most complex diseases. Government grants and funding are expected to boost the research programs for the prevention, diagnosis, treatment, intervention, and discovery of new drugs. To support these researches, focus on sharing and establishment of resources consisting of data, biological samples and information derived from the analysis are taken into consideration.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/life-science-instrumentation-market

R&D budget have been increased around the globe owing to increasing funding, grants and other government support in R&D for drug discovery. The increase in R&D expenditure is also driven by increasing pharmaceutical sales coupled with technological advancement. Significant increase in government funding for R&D programs have boosted drug discovery industry and other associated markets such as life science instrumentation. In 2018, it was stated by the NIH (National Institutes of Health), one of the foremost medical research centers, globally, that it invests around $39 billion for medical research in the US annually. Over 80% of the organization's funding is granted through around 50,000 competitive grants to over 300,000 researchers at research institutions, medical schools, and universities across the US and other economies.

A Full Report of Global Life Science Instrumentation Market is Available at: https://www.omrglobal.com/industry-reports/life-science-instrumentation-market

Advancement in NGS further contribute significantly to the life science Instrumentation market

Next-generation sequencing (NGS), also known as high-throughput sequencing, is the catch-all term that is used to describe a number of different modern sequencing technologies such as Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: Proton / PGM sequencing, SOLiD sequencing and so on. These recent technologies allow us to sequence DNA and RNA much more quickly and cheaply than the previously used Sanger sequencing. Such technologies have therefore revolutionized the study of genomics and molecular biology therefore creating significant market during the forecast period.

Global life science Instrumentation Market Segmentation

By Technology

Chromatography
Spectroscopy
Polymerase Chain Reaction (PCR)
Clinical Chemistry Analyzers
Immunoassays
Next Generation Sequencing (NGS)
Flow Cytometry
Microscopy
Others (Centrifuges, Electrophoresis)

By End-User

Pharmaceutical & Biotechnology Companies
Research Institutes
Hospitals and Laboratories

Global life science Instrumentation Market - Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Latin America
Middle East and Africa

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/life-science-instrumentation-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.